Wells Fargo Downgrades Sherwin-Williams (SHW) to Equal Weight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Sherwin-Williams (SHW) PT Raised to $580 at UBS
January 31, 2020 6:17 AM ESTUBS analyst John Roberts raised the price target on Sherwin-Williams (NYSE: SHW) to $580.00 (from $570.00) while maintaining a Neutral rating.... More
CFRA Downgrades Sherwin-Williams (SHW) to Hold
January 30, 2020 11:29 AM ESTCFRA downgraded Sherwin-Williams (NYSE: SHW) from Buy to Hold.
For an analyst ratings summary and ratings history on Sherwin-Williams click here. For more ratings news on Sherwin-Williams click here.
Shares of Sherwin-Williams closed at $590.26 yesterday.
... MorePre-Open Stock Movers 1/30: (MGEN) (TLSA) (NOW) Higher (SNDL) (BGG) (TSCO) Lower (more...)
January 30, 2020 9:28 AM ESTToday's Pre-Open Stock Movers
miRagen Therapeutics, Inc. (NASDAQ: MGEN) 27.8% HIGHER; announced new efficacy and safety data from the ATLL arm of its ongoing Phase 1 clinical trial of cobomarsen, which will be presented at the 12th Annual T-Cell Lymphoma Forum in La Jolla, CA, which is taking place from January 30th to February 1st. Of note are the data from the subtype of aggressive ATLL patients who at study... More
Sherwin-Williams (SHW) Misses Q4 EPS and Revs
January 30, 2020 7:08 AM ESTSherwin-Williams (NYSE: SHW) reported Q4 EPS of $4.27, ex-items, $0.12 worse than the analyst estimate of $4.39. Revenue for the quarter came in at $4.11 billion versus the consensus estimate of $4.2 billion.
GUIDANCE:
Sherwin-Williams sees FY2020 EPS of $19.91-$20.71, which may not compare to... More
